Perindopril Protection Against Recurrent Stroke Study "PROGRESS"

Completed

Phase N/A Results

Results

Preliminary results: Perindopril group had a 28% relative risk reduction (95% CI 17-38%, p<.0001) in primary endpoint (total strokes).